3 results
The primary objective of the study is to evaluate whether the addition of LABA to ICS therapy (FSC) is non-inferior to ICS therapy alone (FP) in terms of the risk of serious asthma related events (asthma-related hospitalization, endotracheal…
The primary objective of this study is to demonstrate efficacy of BIIB059compared with placebo in participants with active systemic lupuserythematosus (SLE), who are receiving background lupus standard ofcare (SOC) therapy in reducing disease…
The Primary Objective of this Clinical Trial is to evaluate the long-term safety and tolerability of litifilimab in participants with active SLE.The Secondary Objectives of this Clinical Trial are:- to evaluate the long-term effect of litifilimab on…